Drug Trial Radar · NCT03182634
The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
Last checked: Nov 19, 2026Latest source record: Jan 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,150
Planned (sponsor's estimate)
Start
Dec 15, 2016
Primary completion
Nov 2022
Study completion Nov 2023
Sponsor
- Lead sponsor
- Institute of Cancer Research, United KingdomAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Royal Marsden NHS Foundation Trust
- First posted
- Jun 9, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
plasmaMATCH is a multi-centre phase IIa umbrella trial platform consisting of a ctDNA screening component and a therapeutic component. plasmaMATCH aims to assess whether ctDNA screening can be used to detect patient subgroups who will be sensitive to targeted therapies, and will also assess the safety and activity of the targeted treatments.
Conditions
- Advanced Breast Cancer
Interventions
FulvestrantDrug
NeratinibDrug
AZD5363Drug
OlaparibDrug
AZD6738Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint for Cohorts A to E is confirmed objective response rate as defined by RECIST v1.1 for each cohort separatelyTime frame: up to 24 weeks
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Royal Bournemouth Hospital
Bournemouth, United Kingdom · Recruiting
Bristol Haematology and Oncology Centre
Bristol, United Kingdom · Recruiting
Addenbrooke's Hospital
Cambridge, United Kingdom · Recruiting
Velindre Cancer Centre
Cardiff, United Kingdom · Recruiting
Western General Hospital
Edinburgh, United Kingdom · Recruiting
Royal Devon and Exeter Hospital
Exeter, United Kingdom · Recruiting
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom · Recruiting
Clatterbridge Cancer Centre
Liverpool, United Kingdom · Recruiting
Barts Health Trust
London, United Kingdom · Recruiting
Royal Marsden Hospital
London, United Kingdom · Recruiting
University College Hospital London
London, United Kingdom · Recruiting
Kent Oncology Centre
Maidstone, United Kingdom · Recruiting
Christie Hospital
Manchester, United Kingdom · Recruiting
Churchill Hospital
Oxford, United Kingdom · Recruiting
Derriford Hospital
Plymouth, United Kingdom · Recruiting
Weston Park Hospital
Sheffield, United Kingdom · Recruiting
University Hospitals Southampton NHS Foundation Trust
Southampton, United Kingdom · Recruiting
Royal Cornwall Hospital
Truro, United Kingdom · Recruiting
Royal Marsden Hosital
Sutton, England, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.